US President Trump announced deals with Novo Nordisk (NVO) and Eli Lilly (LLY) to secure lower prices of the companies' GLP-1 ...

WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand ...

US President Donald Trump has announced deals that aim to lower the cost of popular weight-loss drugs, as pharmaceutical prices take centre stage in his administration's messaging around affordability ...

A federal judge in Rhode Island has ordered the Trump administration to find the money to fully fund SNAP benefits for ...

House Speaker Mike Johnson (R-LA) distanced himself from a possible deal that could emerge from the Senate on healthcare as ...

Trump announces deal with pharma giants to cut GLP-1 drug costs, including Wegovy and Zepbound, making them more affordable ...

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity ...

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

Eli Lilly and Novo Nordisk will lower prices for GLP-1 drugs, aligning with new drug pricing initiatives and Medicare Part D pilot coverage starting April 2026. Lilly's Zepbound and orforglipron will ...

A shocking moment at the White House as Novo Nordisk executive Gordon Findlay collapses during President Donald Trump’s press ...